309
Participants
Start Date
November 30, 2013
Primary Completion Date
June 30, 2014
Study Completion Date
July 31, 2014
Telmisartan + amlodipine
FDC tablet
hydrochlorothiazide
tablet
Telmisartan + amlodipine
FDC tablet
Placebo
placebo matching hydrochlorothiazide tablet
1348.1.015 Boehringer Ingelheim Investigational Site, Atsubetsu-ku,Sapporo,Hokkaido
1348.1.006 Boehringer Ingelheim Investigational Site, Bunkyo-ku, Tokyo
1348.1.002 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo
1348.1.005 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo
1348.1.031 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo
1348.1.030 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo
1348.1.033 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo
1348.1.016 Boehringer Ingelheim Investigational Site, Chuo-ku,Sapporo,Hokkaido
1348.1.021 Boehringer Ingelheim Investigational Site, Chuo-ku,Tokyo
1348.1.024 Boehringer Ingelheim Investigational Site, Itabashi-ku, Tokyo
1348.1.028 Boehringer Ingelheim Investigational Site, Itoshima, Fukuoka
1348.1.027 Boehringer Ingelheim Investigational Site, Katsushika-ku, Tokyo
1348.1.001 Boehringer Ingelheim Investigational Site, Kishiwada, Osaka
1348.1.009 Boehringer Ingelheim Investigational Site, Kita-ku, Osaka
1348.1.029 Boehringer Ingelheim Investigational Site, Kita-ku, Osaka
1348.1.014 Boehringer Ingelheim Investigational Site, Kiyose,Tokyo
1348.1.003 Boehringer Ingelheim Investigational Site, Koto-ku, Tokyo
1348.1.022 Boehringer Ingelheim Investigational Site, Mihama-ku, Chiba, Chiba
1348.1.004 Boehringer Ingelheim Investigational Site, Miyagino-ku, Sendai, Miyagi
1348.1.017 Boehringer Ingelheim Investigational Site, Moriya, Ibaraki
1348.1.013 Boehringer Ingelheim Investigational Site, Naka-ku,Yokohama,Kanagawa
1348.1.018 Boehringer Ingelheim Investigational Site, Nishi-ku, Fukuoka, Fukuoka
1348.1.007 Boehringer Ingelheim Investigational Site, Okinawa, Okinawa
1348.1.020 Boehringer Ingelheim Investigational Site, Sakaide, Kagawa
1348.1.025 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido
1348.1.026 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido
1348.1.008 Boehringer Ingelheim Investigational Site, Suita, Osaka
1348.1.032 Boehringer Ingelheim Investigational Site, Suita, Osaka
1348.1.019 Boehringer Ingelheim Investigational Site, Takamatsu, Kagawa
1348.1.023 Boehringer Ingelheim Investigational Site, Toshima-ku, Tokyo
Lead Sponsor
Boehringer Ingelheim
INDUSTRY